Circulation:澳大利亚新研究发现卡那利氟嗪可以大幅降低2型糖尿病致命并发症

2018-03-22 Heather_z727 来宝网

卡那利氟嗪(Invokana)是一种SGLT2抑制剂,用于治疗2型糖尿病,在针对10000人进行的临床试验中,这种药物可以降低2型糖尿病患者因心衰住院的风险。

一种降低血糖糖尿病药物也可以降低心脏病的风险】卡那利氟嗪(Invokana)是一种SGLT2抑制剂,用于治疗2型糖尿病,在针对10000人进行的临床试验中,这种药物可以降低2型糖尿病患者因心衰住院的风险。

对于2型糖尿病患者而言,吃得健康和适当的锻炼是两种可以帮助预防未来健康问题的有效方法。但是一项新的研究表明,某种糖尿病药物可能特别有助于防止一种致命的并发症,那些影响心脏的疾病。

研究发表在2018年3月的《循环》杂志中,在研究报告中,作者指出Invokana,一类称为钠葡萄糖协同转运蛋白2(SGLT2)抑制剂的药物,有助于减少2型糖尿病患者死于心脏病,以及因心脏衰竭住院风险。

心脏病是2型糖尿病患者死亡的主要原因。事实上,据《糖尿病护理》杂志2010年2月发表的一篇文章,估计有70%的糖尿病患者死于心脏相关疾病。

来自澳大利亚悉尼大学的心脏病学专家表示:“心力衰竭是2型糖尿病患者的一个主要问题,他们的死亡和需要住院率较高,这增加了患心脏病的风险,前两个主要的临床试验表明,SGLT2抑制剂可能有助于防止心脏衰竭,因此,我们的团队开始分析canagliflozin在糖尿病患者的心脏健康的作用。”

来自波士顿糖尿病中心的内分泌学家表示,有几个理论支持canagliflozin有助于防止心脏衰竭,科学家猜测是药物有助于降低体内循环量,从而防止心脏进入超速。

在这项研究中,研究人员分析了10000多名2型糖尿病患者,研究人员认为他们患心脏病的风险较高。他们根据年龄、心脏病症状史、至少存在两种心脏病危险因素来确定这种风险。美国心脏协会称,高血压、吸烟和血糖控制不当是导致心脏病风险增加的一些因素。所有参与者年龄在30岁以上,平均年龄为63.3岁。大约36%的参与者是女性,64%是男性。整个研究组约有66%有心脏病史。

参与者被随机分配接受canagliflozin或安慰剂,随访平均188周。研究人员发现,与使用安慰剂的参与者相比,接受canagliflozin(100毫克和300毫克之间)的参与者心血管死亡风险降低,因心力衰竭而住院的比例降低,研究人员还发现,有心力衰竭史的患者获益更大。

尽管研究的结果是积极的,但是在对心脏健康研究中,canagliflozin与累及下肢截肢的风险却增加了一倍,研究人员提醒说,这是一个重要的风险,也需要加以考虑。

这项研究的其他空白是排除了4级心力衰竭患者,而且没有分析卡那利氟嗪是否有助于长期预防参与者的心力衰竭,另外两种SGLT2抑制剂Jadiance和Farxiga(Dapagliflzin)目前正在进行研究,以分析这些结果。

研究人员表示:“这些发现很有趣,即将进行的分析服用金利氟嗪的人的心力衰竭结果的试验,将为该药的真正益处提供更多的明确信息。此次研究至少有助于支持先前的证据,即SGLT2抑制剂如canagliflzin应该在治疗初期就被考虑,特别是在心力衰竭的高风险时”。

原始出处:

Karin Rdholm, Gemma Figtree, Vlado Perkovic, et al. Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study). Circulation. 2018;CIRCULATIONAHA.118.034222.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1753381, encodeId=07621e53381a8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jul 15 11:02:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757959, encodeId=00d71e57959ea, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Thu May 24 20:02:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483950, encodeId=bfa81483950b6, content=<a href='/topic/show?id=66a666e3784' target=_blank style='color:#2F92EE;'>#澳大利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66737, encryptionId=66a666e3784, topicName=澳大利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33da7929339, createdName=12498cbcm02(暂无昵称), createdTime=Sat Mar 24 03:02:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298639, encodeId=e28f298639b8, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Mar 22 12:56:29 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298629, encodeId=9a6e29862906, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Thu Mar 22 12:10:43 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1753381, encodeId=07621e53381a8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jul 15 11:02:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757959, encodeId=00d71e57959ea, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Thu May 24 20:02:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483950, encodeId=bfa81483950b6, content=<a href='/topic/show?id=66a666e3784' target=_blank style='color:#2F92EE;'>#澳大利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66737, encryptionId=66a666e3784, topicName=澳大利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33da7929339, createdName=12498cbcm02(暂无昵称), createdTime=Sat Mar 24 03:02:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298639, encodeId=e28f298639b8, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Mar 22 12:56:29 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298629, encodeId=9a6e29862906, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Thu Mar 22 12:10:43 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
    2018-05-24 丁鹏鹏
  3. [GetPortalCommentsPageByObjectIdResponse(id=1753381, encodeId=07621e53381a8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jul 15 11:02:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757959, encodeId=00d71e57959ea, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Thu May 24 20:02:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483950, encodeId=bfa81483950b6, content=<a href='/topic/show?id=66a666e3784' target=_blank style='color:#2F92EE;'>#澳大利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66737, encryptionId=66a666e3784, topicName=澳大利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33da7929339, createdName=12498cbcm02(暂无昵称), createdTime=Sat Mar 24 03:02:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298639, encodeId=e28f298639b8, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Mar 22 12:56:29 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298629, encodeId=9a6e29862906, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Thu Mar 22 12:10:43 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1753381, encodeId=07621e53381a8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jul 15 11:02:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757959, encodeId=00d71e57959ea, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Thu May 24 20:02:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483950, encodeId=bfa81483950b6, content=<a href='/topic/show?id=66a666e3784' target=_blank style='color:#2F92EE;'>#澳大利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66737, encryptionId=66a666e3784, topicName=澳大利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33da7929339, createdName=12498cbcm02(暂无昵称), createdTime=Sat Mar 24 03:02:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298639, encodeId=e28f298639b8, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Mar 22 12:56:29 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298629, encodeId=9a6e29862906, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Thu Mar 22 12:10:43 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
    2018-03-22 清风拂面

    谢谢分享学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1753381, encodeId=07621e53381a8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sun Jul 15 11:02:00 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757959, encodeId=00d71e57959ea, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Thu May 24 20:02:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483950, encodeId=bfa81483950b6, content=<a href='/topic/show?id=66a666e3784' target=_blank style='color:#2F92EE;'>#澳大利亚#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66737, encryptionId=66a666e3784, topicName=澳大利亚)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33da7929339, createdName=12498cbcm02(暂无昵称), createdTime=Sat Mar 24 03:02:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298639, encodeId=e28f298639b8, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Mar 22 12:56:29 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298629, encodeId=9a6e29862906, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Thu Mar 22 12:10:43 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
    2018-03-22 戒馋,懒,贪

    谢谢分享学习了

    0

相关资讯

重磅!这种新型降糖药有望开发成抗脂肪肝新药!

在2型糖尿病患者中,非酒精性脂肪性肝病(NAFLD)很常见,并可发展为严重肝脏疾病,即非酒精性脂肪性肝炎(NASH)。现在一项研究发现,empagliflozin是一种新型的2型糖尿病治疗药物,可减少NAFLD和糖尿病患者的肝脏脂肪。这项名为E-LIFT试验的随机对照研究的结果将在周一举行的内分泌学会第100届年会上在伊利诺伊州芝加哥举行,会议将在最新一期的摘要会议上公布。

Lancet Diabetes Endo:糖尿病结构化自我管理教育项目的实施情况

糖尿病自我管理可改善结局,糖尿病结构化自我管理的教育项目可提高糖尿病患者自我管理的水平。发表在《Lancet Diabetes Endocrinol》的一篇文章详细叙述了过去20年糖尿病自我管理教育项目的进展。

带你认识强化降糖“记忆效应”的真实面目!

现行国内外指南多推荐将2型糖尿病患者糖化血红蛋白(HbA1c)控制在6.5%~7.0%以下。相比之下,ACP新指南做出了更为宽松的血糖管理建议。正如预期,这一指南颁布后迅速受到很多学者的反对。一些学者再次亮出杀手锏“强化降糖的记忆效应”(legacy effects),以此作为支持强化降糖的依据,并否认ACP新指南的观点。

如果您的亲人患有2型糖尿病,如果不运动你患糖尿病的概率比其他人更大

利物浦大学的科学家发现,体力活动的减少和久坐行为的增加对身体有不利影响,如果一级亲属患有2型糖尿病,可能会更有害。

Inter J Cancer:2型糖尿病和结直肠癌存活率的新发现

“国际癌症杂志”发表的一项研究调查了患有或不患有2型糖尿病的结直肠癌患者和其他疾病,如心脏病或中风的存活率。研究结果显示单纯2型糖尿病对结直肠癌患者的生存没有显著影响。然而,2型糖尿病患者以及其他慢性病患者的生存率较低。